maybe. maybe not. Playing with the gods creations is not v safe
Albinism is typically caused by a recessive gene.
Yes. If either parent is a carrier of the gene that causes albinism then their child becomes a carrier as well. It is only when both parents have the gene for albinism that the child is born with this disorder.
Cystic fibrosis is an example of a disease that might be treated using gene therapy. This genetic disorder affects the lungs and digestive system, and gene therapy could potentially be used to correct the underlying genetic mutation that causes the disease.
genetically albinism is an autosomal recessive gene which in fact gives the child a 25% chance of inheriting the gene if both parents are carriers
Albinism is a recessively inherited disease. People with albinism has inherited 2 albinism genes. They got one gene from each parent.
at the gene level gene therapy is done and at the the protein level protein therapy is done
Overall, the survival rate for gene therapy treatments is quite high, with some treatments showing success rates above 90%. However, the exact percentage can vary depending on the specific genetic disorder being treated, the stage of the disease, and the individual patient's response to the therapy. It is important to consult with a healthcare provider for accurate and up-to-date information on survival rates for specific gene therapy treatments.
yo mammas mamma
That process is called gene therapy. It involves inserting functional copies of a gene into the cells of a person with a genetic disorder to correct the genetic mutation causing the disorder.
Recessive. The trait will only show up if both parents have the gene recessively (aa). If the genetic make up is Aa or AA, there will be melanin production, meaning albinism is an aa gene only. Albinism is a recessive allele.
Many of the more commonly occurring disorders, including heart disease, diabetes, and high blood pressure, result from defects in multiple genes making them unlikely candidates for gene therapy using existing technologies.
Gene therapy may not always work due to challenges in delivering the therapeutic gene to the target cells, potential immune responses, difficulty in achieving sustained gene expression, and the complexity of genetic diseases. Additionally, off-target effects, limited understanding of gene function, and ethical concerns surrounding genetic manipulation can also impact the success of gene therapy.